Clinical trial

Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers

NCT07259226

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-11-14

PhasePHASE2

Study timeline

Study start (actual)2025-11-14Date precision: day

Registry last updated2025-12-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Breast Cancerunresolved

Advanced Gastric Cancerunresolved

Advanced Urothelial Cancerunresolved

Advanced Non Small Cell Lung Cancer (NSCLC)unresolved

Interventions

Biological samples collectionPROCEDURE

questionnaires to collect patient reported outcomesBEHAVIORAL

Sponsors & collaborators

UNICANCERlead sponsor

Mapped research locations

VillejuifFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07259226 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.